Dermal Filler Market Analysis

Dermal Filler Market Analysis

To get key market trends

  Download Free Sample

By product type, the dermal filler market is classified into absorbable and non-absorbable. The absorbable segment accounted for 94.7% of the market share in 2022. Absorbable materials refer to substances that can be naturally broken down and absorbed by the body over time. Unlike permanent materials or implants, absorbable materials are designed to be temporary and gradually degrade within the body. This feature provides consumers with the flexibility to experiment with their appearance and make changes without committing to permanent alterations.

Based on material type, the dermal filler market is segmented into hyaluronic acid (HA), calcium hydroxylapatite, poly-L-lactic acid, polymethyl-methacrylate microspheres (PMMA), collagen, fat fillers, and other material types. The material type segment is further divided based on their application. The hyaluronic acid (HA) is expected to register around USD 8.6 billion by 2032. Hyaluronic acid (HA) dermal fillers offer several advantages. HA is a biocompatible substance that is naturally present in the body thus, minimizing the risk of adverse reactions and allergic responses. Furthermore, the ability of HA fillers to target different areas and concerns makes them a popular choice among both patients and cosmetic professionals.

The hyaluronic acid (HA) is further categorized based on its application including face lift, facial corrections, wrinkles reduction, breast enhancement, acne scar treatment, lip enhancement, and others application. The face lift segment in hyaluronic acid (HA) accounted for 10.1% of the market share in 2022.  The versatility of HA fillers in various treatment areas and their compatibility with other aesthetic procedures will further contribute to market expansion.

By application, the dermal filler market is segmented into face lift, facial corrections, wrinkles reduction, acne scar, lipoatrophy, lip enhancement, hip augmentation, breast enhancement, hand rejuvenation, penis enlargement, blepharoplasty, neck & chin lift, and other applications. The lip enhancement segment is expected to grow at a considerable CAGR of 11.1% during the forecast period. The rising demand for fuller and more defined lips among individuals seeking to enhance their facial aesthetics will fuel the progress of this segment.

Additionally, advancements in dermal filler technology and techniques have enabled healthcare professionals to deliver precise and customized lip enhancements, thereby propelling market development. Moreover, the non-invasive nature of lip enhancement procedures using dermal fillers appeals to a broader consumer base, offering convenient and efficient solutions without the need for surgical interventions.

The end-use in dermal filler market is divided into hospitals, dermatology clinics, and other end-users. Dermatology clinics accounted for USD 3.1 billion market revenue in 2022. The presence of qualified plastic surgeons worldwide, an increase in the number of clinics offering specialised services, and rising healthcare infrastructure will all have a positive impact on the segment’s growth in the forthcoming years. Furthermore, increasing acceptance of anti-aging treatment among the women in developed countries along with expanding healthcare facilities is anticipated to witness increased patient inflow in dermatological clinics. These clinics offer personalized and customized cosmetic treatments.

North America dermal filler market accounted for 35.7% business share in 2022.The regional growth is primarily attributable to the growing adoption of several facial procedures including injectables for better facial appearance. The region has witnessed a significant trend shift from invasive to non-invasive treatments.

For instance, according to the report published by the American Society of Plastic Surgeons (ASPS), in 2020, more than 15.5 million minimally invasive and surgical aesthetic procedures were conducted in the U.S. Adding to this, increasing product availability with rising number of product approvals by the U.S. FDA will expand product accessibility which will further contribute to regional value.